Join FierceBiotech for an Executive Breakfast at the J.P. Morgan Healthcare Conference

Dear Colleague,

Will you be at the J.P. Morgan Healthcare Conference in January? If so, I wanted to make sure you heard about our upcoming FierceBiotech Executive Breakfast, Get Good Science and the Money will Follow on January 9th at the Fairmont Hotel in San Francisco. The event will run from 7:00AM-8:30AM and will include a full buffet breakfast.

Biotech IPOs struggled until the second quarter of 2017, but investments through early raises in young biotechs reached major levels – with around half of 2016 Fierce15 winners seeing a $50M series A or B round in 2016 or 2017. And the rebound doesn’t appear to be based solely on a more positive economic outlook, but a belief in some genuinely exciting science, from gene therapy and gene editing, to new waves in immunology and immuno-oncology, to RNAi and more.

Risk is inherent in science and some of these ideas will inevitably fail. But the enthusiasm and faith, backed up by VC and private investor wallets, in this embryonic science is growing. Are we seeing a genuine reblooming of biomedical innovation, and is biotech, notably young biotech, ready to bring in the money, partners and investors needed to fuel R&D?

Seats are limited and our early bird rate ends November 17th, so don’t delay. Click here to reserve your seat today.

I hope to see you in San Francisco, and thanks for being a part of the Fierce community.

Best,

Rebecca Willumson
Publisher
FierceBiotech

This blast was sent on behalf of FierceBiotech.
Click here to unsubscribe or to manage your subscriptions.